[Prokinetics in childhood].
Gottrand
F
F
Faculté de Médecine, Pôle Enfant, Hôpital Jeanne-de-Flandre, CHRU de Lille, Université Lille2, France. fgottrand@chru-lille.fr
D000293:Adolescent; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use; D018723:Bethanechol / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D020117:Cisapride / Q000009:adverse effects / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D004294:Domperidone / Q000009:adverse effects / Q000627:therapeutic use; D005602:France; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008787:Metoclopramide / Q000009:adverse effects / Q000627:therapeutic use; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000009:adverse effects / Q000627:therapeutic use; D014287:Trimebutine / Q000009:adverse effects / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D000932:Antiemetics; D005765:Gastrointestinal Agents; D010276:Parasympatholytics; D010277:Parasympathomimetics; D018723:Bethanechol; D004294:Domperidone; D008787:Metoclopramide; D014287:Trimebutine; D020117:Cisapride